Brief: Acumen Pharmaceuticals Reports Financial Results For Full Year Ended December 31
28/03/2022 21:15
March 28 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O :
* ACUMEN PHARMACEUTICALS REPORTS FINANCIAL RESULTS FOR FULL
YEAR
ENDED DECEMBER 31, 2021 AND BUSINESS HIGHLIGHTS
* ACUMEN PHARMACEUTICALS - $225.9 MILLION IN CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES AT DEC 31, 2021, EXPECTED
TO PROVIDE CASH RUNWAY THROUGH 2025
* ACUMEN PHARMACEUTICALS INC - TOPLINE RESULTS FROM
INTERCEPT-AD
NOW EXPECTED IN FIRST HALF OF 2023
Source text for Eikon: ID:nGNXPQcT5
Further company coverage: ABOS.O
((Reuters.Briefs@thomsonreuters.com;))